The connection between FGF23 and phosphate serum levels has raised interest in investigating FGF23 as a potential marker for disturbed phosphate metabolism in chronic kidney disease (CKD) in humans [15,16], cats [17,18], and dogs [19]. Here, FGF23 is linked to chronic kidney disease.